Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.3B | 3.4B | 3.2B | 3.2B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3B | 1.3B | 1.2B | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 822M | 960M | 925M | 912M |
Tax provision | 178M | 177M | 195M | 201M |
Net income | 644M | 783M | 730M | 711M |
Basic EPS | 2.1 | 2.5 | 2.3 | 2.2 |
Diluted EPS | 2.0 | 2.5 | 2.3 | 2.2 |
Basic average shares | 288.6M | 291.7M | 297.4M | 300.6M |
Diluted average shares | 292.7M | 296.4M | 301.8M | 304.8M |
EBITDA | — | — | — | — |
Net income from continuing op. | 644M | 783M | 730M | 711M |
Minority interests | — | — | — | — |
Preferred stock dividends | 1M | 1M | — | 1M |